Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Genetic repair. Bruce A. Sullenger, Series Editor
Ribozyme-mediated revision of RNA and DNA
Meredith B. Long, … , Bruce A. Sullenger, Jonghoe Byun
Meredith B. Long, … , Bruce A. Sullenger, Jonghoe Byun
Published August 1, 2003
Citation Information: J Clin Invest. 2003;112(3):312-318. https://doi.org/10.1172/JCI19386.
View: Text | PDF
Perspective Series

Genetic repair. Bruce A. Sullenger, Series Editor
Ribozyme-mediated revision of RNA and DNA

  • Text
  • PDF
Abstract

Authors

Meredith B. Long, J.P. Jones III, Bruce A. Sullenger, Jonghoe Byun

×

Figure 3

Options: View larger image (or click on image) Download as PowerPoint
Group II intron mobility and revision of DNA. Mechanism of Group II L1.L...
Group II intron mobility and revision of DNA. Mechanism of Group II L1.LtrB intron mobility. (a) A Group II intron (red) is found in the ltrB gene (green) of Lactococcus lactis between exons E1 and E2. The intron encodes the LtrA gene product (blue). Following transcription of the ltrB gene, the LtrA protein is translated from the intron-containing precursor. The LtrA protein facilitates self-splicing of the L1.LtrB intron. The excised intron is in the form of a lariat that is bound to the LtrA protein in an RNP particle. The assembled RNP targets an intronless allele for insertion into the DNA. The RNA component reverse-splices into the sense strand at the junction between E1 and E2. The LtrA protein then cleaves the antisense strand downstream of the intron insertion site, providing a template for reverse transcription by the LtrA protein. Second-strand synthesis and DNA repair complete the intron’s mobilization into the target DNA. (b) Target-site recognition by the retrohoming RNP is shown in greater detail. The EBSs of the intron (EBS1, EBS2, and δ) pair with IBSs IBS1, IBS2, and δ′ in the target (shown in red). Two bp’s, at –21 and +5 (shown in blue), strongly influence the activity of the LtrA protein during retrohoming (6). Cleavage sites are shown by the arrows. The top (sense) strand is cleaved by the RNA. LtrA cleaves the bottom strand following reverse splicing of the intron.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts